Minor
DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Delta-Fly Pharma, Inc.Phase 1/2 NCT06382168 Registry history of NCT06382168 on ClinicalTrials.gov (opens the registry)
Changed